Brown Adipose Tissue Activation by Spinal Cord Stimulation
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Oregon Health and Science University
- Study ID
- NCT04326192
- Status
- Recruiting
Conditions
- Obesity, Morbid
- Pain, Back
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Research electrode — DEVICEA second electrode will be placed percutaneously by Tuohy needle in the epidural space at the same time as the SCS trial implant; at lateral T1-2 area randomly assigned to the left or right side of the lateral epidural space, at the time of the procedure. Placement of electrodes is not experimental, but the placement of a second electrode is a research-driven procedure.
Study Details
The objective of this study is to investigate and utilize spinal cord stimulation (SCS) as an effective approach to eliciting weight loss and potentially alleviating Type 2 diabetes mellitus (DM), as evidenced by increasing metabolism of adipose tissue.
Key Dates
- Start date
- Feb 19, 2021
- Status verified
- Apr 2024
- Primary completion
- Oct 31, 2025
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: All subjectsAll subjects will have two PET/CT scans on days 3 and 5 after SCS electrode implantation: (1) Baseline and (2) SCS-activated. Other than SCS activation, both studies will be conducted under identical conditions. For the first scan, subjects will be randomly assigned to either a baseline (no SCS during PET/CT) or with SCS during PET/CT prior to the day of their first scan. The second scan will complete the sequence with either a baseline or SCS-activated scan, as randomized.
Primary Outcome Measure
SUVmax [ Time Frame: 1 week ]
Central Contacts
- Kim Burchiel, MD503-494-4314
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oregon Health & Science University | Portland | Oregon | 97239 | Kim Burchiel, MD 503-494-4314 |
Find similar trials in Portland, OR
By condition
By specialty
By research site
Related Studies
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)PHASE2 · Recruiting · Sparrow Pharmaceuticals · Chandler, Arizona
- Bariatric Surgery RegistryEnrolling By Invitation · Virginia Commonwealth University · Richmond, Virginia
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York